相关实验视频
Updated: Jun 12, 2025

11:21
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
19.6K
导管切除对于心房动:指示和未来的前景
Andrea Natale1,2,3,4, Sanghamitra Mohanty1, Prashanthan Sanders5
1Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N. I-35, Suite 720, Austin, TX 78705, USA.
European heart journal
|September 25, 2024
概括
导管切除是对心房动 (AF) 的主要治疗方法,为药物提供了优越的结果. 目前正在进行的进展重点是改善病变的耐用性,并针对非肺静脉触发因素,以更好地长期控制节律.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗技术 医疗技术 医学技术
背景情况:
- 在全球范围内,心房动 (AF) 的患病率正在上升,特别是在老年人群中.
- 导管切除在AF管理中的有效性已经超过了抗不律性药物.
- 实现稳定的鼻节律对于改善生活质量和减少AF并发症至关重要.
研究的目的:
- 审查当前的指示和在心房动的导管切除的进展.
- 探索复杂的AF病例的肺静脉隔离之外的新兴策略.
- 讨论 AF 消去技术和目标的未来前景.
主要方法:
- 审查最近的临床试验和AF切除技术创新.
- 对既有和新的废除策略的分析,包括肺静脉隔离 (PVI) 和其他.
- 讨论辅助废弃技术和不断发展的废弃技术.
主要成果:
- 肺静脉隔离 (PVI) 仍然是 Paroxysmal AF (PAF) 的主要策略.
- 对于非囊性AF的辅助废除策略显示出混合的结果,需要进一步研究.
- 早期节律控制和针对非PV触发器越来越被认为是预防复发和进展的重要因素.
结论:
- 导管切除是AF的基石治疗方法,技术不断发展.
- 优化除了PVI之外的切除策略对于管理持续性AF和防止复发至关重要.
- 未来的方向包括增强病变的创建和识别新的废弃目标,以改善患者的治疗结果.
相关概念视频
Dysrhythmias VI: Management of Dysrhythmias
3
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
3
Disturbances in Heart Rhythm
916
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
916
Cardiomyopathy V: Interprofessional Care
2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Cardiopulmonary Resuscitation III: AED Use
2
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
2
Dysrhythmias V: Evaluating Dysrhythmias
24
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.1. Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
24
Cardiopulmonary Resuscitation IV: Pharmacological Management
2
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
2

